Mainboard · BSE and NSEDraft filed

GAMP Services Limited IPO: dates, price band, lot size, objects of the issue

Get updates on this IPO

Dates, price band, allotment and listing notices by email, and new views from SEBI-registered research analysts on InsightPier by email.

Dates, allotment, listing and analyst views. Stop anytime.

By continuing you agree to the Terms and Privacy policy

Updated Sun 15 Nov 2026, 8:04 pm IST · Source: DRHP dated Sun 18 Oct 2026

Key facts

Price band
Not announced
Lot size
Not announced
Lot amount at the upper band
Not announced
Issue size at the upper band
46,93,500 shares (Amount not stated in the draft)
DRHP dated Sun 18 Oct 2026, page 1
Fresh issue
31,93,500 shares (Amount not stated in the draft)
DRHP dated Sun 18 Oct 2026, page 1
Offer for sale
15,00,000 shares (Amount not stated in the draft)
DRHP dated Sun 18 Oct 2026, page 1
Bid dates
Not announced
Listing date
Not announced
Risk factors
80
DRHP dated Sun 18 Oct 2026, page 90
Proposed exchanges
BSE and NSE

Timeline (IST)

  1. Draft filedWed 21 Oct 2026 confirmedDRHP dated Sun 18 Oct 2026
  2. OpensDates to be announced
  3. ClosesDates to be announced
  4. AllotmentDates to be announced
  5. Refund and unblockDates to be announced
  6. ListingDates to be announced

Objects of the issue

ObjectAmount
Funding capital expenditure towards purchase of equipment and IT hardware for our Services and Data Logger Manufacturing verticals₹40.05 crore
Funding inorganic growth through unidentified acquisitions and general corporate purposesNot stated in the draft
TotalNot stated in the draft

The offer for sale goes to the selling shareholders, not the company. DRHP dated Sun 18 Oct 2026, page 132

Company and promoters

As described in the DRHP

We are a compliance and validation company providing validation, qualification and instrumentation solutions to customers operating primarily in regulated industries. Our services support customers in establishing, qualifying, operating and maintaining manufacturing facilities, utilities, equipment and computerised systems in accordance with applicable regulatory and quality requirements.

DRHP dated Sun 18 Oct 2026, page 240

Promoters

  • 3 individual promoters

DRHP dated Sun 18 Oct 2026, page 321

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group99.99%Not stated in the DRHP

DRHP dated Sun 18 Oct 2026, page 121

Who is selling in the offer for sale

Selling shareholderTypeShares offeredAmount at the upper band
Individual shareholderIndividual6,20,700Not announced
Individual shareholderIndividual6,20,700Not announced
Individual shareholderIndividual2,58,600Not announced
Total offer for saleNot announced

DRHP dated Sun 18 Oct 2026, page 1

Risk factors

80 total
  1. Most revenue comes from life sciences customers, mainly pharmaceutical companies (DRHP page 32)
  2. Heavy reliance on the services vertical; lower demand for validation services could hurt results (DRHP page 34)
  3. Most purchases come from foreign suppliers, exposing the company to supply chain disruption (DRHP page 35)
  4. Purchases are concentrated among the top ten suppliers (DRHP page 36)
  5. Exchange rate movements may affect the value of the shares (DRHP page 89)

All 80 risk factors, DRHP pages 32 to 90

Offer document

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts